Manning & Napier Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150M | Sell |
|
|||||
|
2025
Q1 | $225M | Sell |
|
|||||
|
2024
Q4 | $245M | Buy |
|
|||||
|
2024
Q3 | $248M | Buy |
|
|||||
|
2024
Q2 | $188M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $13.5M | Hold |
|
|||||
|
2016
Q3 | $16.3M | Buy |
|
|||||
|
2016
Q2 | $14.7M | Hold |
|
|||||
|
2016
Q1 | $13.7M | Buy |
|
|||||
|
2015
Q4 | $15.6M | Buy |
|
|||||
|
2015
Q3 | $14.5M | Hold |
|
|||||
|
2015
Q2 | $14.5M | Hold |
|
|||||
|
2015
Q1 | $15.6M | Hold |
|
|||||
|
2014
Q4 | $16M | Sell |
|
|||||
|
2014
Q3 | $22.7M | Buy |
|
|||||
|
2014
Q2 | $23M | Sell |
|
|||||
|
2014
Q1 | $29.8M | Sell |
|
|||||
|
2013
Q4 | $29.1M | Sell |
|
|||||
|
2013
Q3 | $26.4M | Sell |
|
|||||
|
2013
Q2 | $24.2M | Buy |
|